OASIS Mailing List ArchivesView the OASIS mailing list archive below
or browse/search using MarkMail.

 


Help: OASIS Mailing Lists Help | MarkMail Help

etmf-comment message

[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]


Subject: OASIS TMF Standard


Section 1.3: It is not clear of the intention for inclusion of Non-Normative references. Would it be more appropriate to use references that are normalized and adopted across the industry?

 

Section 6.2:

Suggest revising the statement: ‘Electronic and digital signatures enable the removal of wet signatures on paper’ to

‘Eliminates the need for a document created electronically to be converted to paper to be signed with wet ink’

 

Section 6.3 Business Process Model

Having a section on Business Process Model doesn’t seem to align with the purpose of this document. If there is to be guidance and direction around a business process then it is suggested to create a separate document purely for Business Process. Although, it is not clear how much standardisation can be obtained from this. Additionally,  this section is mapped to a non-normative technical standard by OMG. Suggest defining Universal Standards for minimum business process requirements consistent across the industry.

 

Overall Comment:

Understanding how the references tie in with the standards proposed, a 45 day review period is not sufficient to provide a comprehensive and constructive review of the documentation.  Suggest sub committees to be established for sections 4-7 with representatives from across the industry to provide both technical and business input to enable a robust standard for the portability of TMF documentation. 

 

 

Martin

TMF Content Integration Lead  (Questions about TMF?  Go to tmf.pfizer.com)

Office: +44(0)1304648181   Mobile: +44(0)7968065123  email martin.thorley@pfizer.com

CTPQ - Securing GCP Quality & Process Excellence in Our Portfolio

DevelopmentOperations-CTPQ_Signature.jpg

 

 

        

PFIZER INTERNAL USE

LEGAL NOTICE
    
Unless expressly stated otherwise, this message is confidential and may be privileged. It is intended for the addressee(s) only. Access to this e-mail by anyone else is unauthorised. If you are not an addressee, any disclosure or copying of the contents of this e-mail or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you are not an addressee, please inform the sender immediately.

    
Pfizer Limited is registered in England under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent CT13 9NJ 

 

 

 

 



[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]